These large- and mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos have upside potential of up to 25%, according to analystsTalk of tariffs, especially steep ones, makes the market nervous. Which is exactly why the next few trading sessions are critical, and why ...
18 Sep, 2026, 01.39 PM IST
Hospitals seek new pricing rules as Maharashtra FDA flags high markupsThe healthcare industry seeks a differentiated framework for medical device pricing reviews. Hospitals incur significant costs beyond procu...
17 Sep, 2026, 11.14 AM IST
Supreme Court upholds Himachal HC ruling on drug regulator powers, impacting CDSCO enforcementThe Supreme Court dismissed the Union government's challenge to a High Court judgment. This ruling clarified jurisdiction over drug regulat...
17 Sep, 2026, 01.25 AM IST
'We unleashed the beast': the world's fears and hopes about AIGlobal discussions are occurring about regulating artificial intelligence development. People in various countries share fears and hopes fo...
15 Sep, 2026, 01.42 PM IST
India’s food safety rules are giving restaurants heartburn: It’s the process, not just the productIndia’s food safety regime has shifted from testing adulteration in the final product to policing the processes that prevent it. Restaurant...
11 Sep, 2026, 11.48 PM IST
Alembic Pharma clears USFDA inspection at Vadodara bioequivalence facility with nil observationsAlembic Pharmaceuticals has reported that its Vadodara facility passed the recent inspection by the United States Food and Drug Administrat...
11 Sep, 2026, 02.18 PM IST
Graph AI raises $13.3 million from Insight Partners, Bessemer to scale AI-native patient-safety platformThe new funds will be used to expand across the US and Europe, as the startup looks to change the pharmacovigilance industry’s services-hea...
11 Sep, 2026, 10.47 AM IST
Beyond Los Angeles and Rotterdam: Can Durban, Rio de Janeiro drive India’s next export boom?The South-South trade has crossed $7 trillion, opening new opportunities for Indian exporters across Africa, ASEAN, the Gulf, and Latin Ame...
10 Sep, 2026, 07.48 AM IST
Prasol Chemicals IPO Day 2: GMP, subscription status. Should you subscribe?Prasol Chemicals IPO saw 72% subscription by Day 2, with retail investors showing strong interest. The grey market premium remains modest a...
09 Sep, 2026, 06.49 PM IST
Prasol Chemicals IPO opens for bidding. Check GMP and other key detailsThe Prasol Chemicals IPO opened for subscription on September 8 and will remain open until September 10. The Rs 500 crore issue comprises a...
08 Sep, 2026, 09.54 AM IST
- Govt mandates manual verification of imported drugs and medical devices due to SWIFT 2.0 system gap
Customs officers must now manually check import documents for healthcare products. This manual verification applies even to facilitated imp...
07 Sep, 2026, 12.15 AM IST
Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...
06 Sep, 2026, 11.21 PM IST
Lupin gets USFDA approval for Modafinil tablets to treat excessive sleepinessPharmaceutical major Lupin announced its USFDA approval for Modafinil tablets. These tablets are used to treat excessive sleepiness in adul...
04 Sep, 2026, 07.01 PM IST
After Adani, Tata feels the heat: Indian firms under fire in Kenya?Kenya’s dispute with Tata Chemicals has revived concerns about Indian businesses in the country after Adani’s exit. But Kenya continues to ...
04 Sep, 2026, 05.44 PM IST
Drug cos refuse to take sole responsibility for overpricingIndian drugmakers oppose a proposal making them solely liable for medicine overpricing. This regulatory move exempts retail chemists, hospi...
04 Sep, 2026, 12.51 AM IST
Daiichi-Ranbaxy case: Delhi HC orders forensic audit into transactions of Fortis, Singh brothersThe Delhi High Court has appointed a forensic auditor to examine transactions. This audit aims to trace the dissipation of Fortis Healthcar...
01 Sep, 2026, 09.24 AM IST
Global buyers care less about where SaaS is built, more about what it delivers: SmartWinnr CEOSmartWinnr CEO Anindita Banik on why India’s SaaS companies are increasingly being judged on product quality and performance, rather than t...
31 Aug, 2026, 10.52 AM IST